If you've dismissed brain training apps before, you had good reasons. Lumosity's fine from the FTC. Exaggerated IQ claims. No outcome data. No way to monitor patients. Soillse is built differently — and this page is written for the clinician who needs specifics, not marketing.
What this page covers: What Soillse is and isn't, which paradigms it uses and their evidence base, which patient populations are appropriate, how to integrate it into clinical workflows, how to access patient progress data, and what clinical questions remain open.
On efficacy claims: Soillse does not claim to improve general intelligence or prevent disease. It uses validated cognitive science paradigms and allows individuals to practice cognitive skills with adaptive difficulty. Whether that produces meaningful real-world transfer varies by individual, domain, and engagement level — as the published literature shows.
On clinical validation: Soillse's specific implementation has not been tested in randomised controlled trials. The paradigms it uses have been. We make this distinction explicit throughout the platform and in all patient-facing materials.
On monitoring: Users can generate a shareable progress report from the Progress screen. It includes session frequency, domain scores over time, and a table mapping Soillse's tasks to the standardised instruments they approximate. The limitations of this mapping are disclosed.
On patient populations: See the appropriate use section below. Soillse is not appropriate as a primary intervention for acute psychiatric conditions, severe cognitive impairment, or as a replacement for any prescribed treatment.
A self-directed cognitive training application using validated paradigms from neuropsychology research. Appropriate as an adjunct to clinical care for motivated patients. A source of structured cognitive engagement between clinical appointments. A tool for tracking performance trends over time.
Not regulated as a medical device. Not evaluated by the FDA, Health Canada, or any health authority. Not a replacement for clinical assessment, therapy, or medication. Not a diagnostic tool. Not a clinical intervention. Soillse has not been tested in clinical trials for efficacy in any patient population.
Every game in Soillse targets a specific cognitive system using a paradigm from the peer-reviewed literature. The table below maps each paradigm to its published source and established clinical use. This is not a claim that Soillse produces the same outcomes — it is a transparency statement about what the tasks are modelled on.
| Soillse Game | Paradigm | Source | Clinical Use |
|---|---|---|---|
| Echo Grid | Dual N-Back | Jaeggi et al., PNAS 2008 | Working memory assessment and training; used in ADHD research |
| Number Chain | Digit Span (forward/backward) | WAIS-IV; Wechsler 2008 | Standard WM subtest in neuropsychological batteries |
| Colour Word | Stroop Colour-Word | Stroop 1935; Golden 1978 | Cognitive flexibility, response inhibition; widely used in clinical practice |
| Stop Signal / Go No-Go | Stop-Signal Paradigm | Logan 1984; Verbruggen & Logan 2008 | Response inhibition; primary measure in ADHD, impulse control research |
| Name Things | Category Verbal Fluency | Benton 1968; MoCA item | Dementia screening, aphasia assessment, TBI evaluation |
| Echo Grid (Corsi) | Corsi Block-Tapping | Corsi 1972; Milner 1971 | Visuospatial WM; used in TBI, stroke, dementia assessment |
| Rapid Sort | Wisconsin Card Sort variant | Berg 1948; Heaton et al. 1993 | Executive function; frontal lobe assessment, TBI, schizophrenia |
| Tower Plan | Tower of London | Shallice 1982 | Planning, executive function; frontal lobe, ADHD assessment |
| Mind Reading (ER) | Reading the Mind in the Eyes | Baron-Cohen et al. 1997 | Social cognition; ASD assessment, empathy research |
| Reframe It (ER) | Cognitive Reappraisal paradigm | Ochsner & Gross 2005; Gross 1998 | Emotion regulation therapy; CBT, DBT research basis |
| False Belief (SC) | Sally-Anne task | Wimmer & Perner 1983 | Theory of Mind assessment; ASD, frontal lobe evaluation |
| Social Slip (SC) | Faux Pas Test | Baron-Cohen et al. 1999 | Advanced ToM; frontal lobe, ASD assessment |
| Remote Associates | Compound Remote Associates | Mednick 1962 | Creativity, divergent thinking research |
Soillse domain scores (0-100) are not validated against normative data. They reflect performance on tasks modelled on standardised instruments. The table below provides approximate mappings to help contextualise scores. These approximations should be treated as screening indicators only, not clinical measurements.
The mappings below are approximations based on task similarity, not empirical validation. Soillse scores should never be used in place of standardised clinical assessment. They may be useful as a general indicator of relative performance across domains or as a conversation starter with a patient — not as a clinical measurement.
If a domain score is consistently low across multiple sessions, this may warrant further clinical assessment using validated tools — particularly for working memory, processing speed, verbal fluency, and executive function.
Soillse is most appropriate as a structured cognitive engagement tool for motivated patients who can use a smartphone or computer independently. The following guidance is based on the paradigm literature and clinical reasoning — not on Soillse-specific outcome data.
Processing speed and attention training are the most evidence-supported interventions for long-COVID cognitive symptoms. Restore mode's low-pressure design reduces the fatigue-exacerbation risk.
Structured cognitive engagement during post-acute recovery. Restore mode with no timers and self-paced difficulty is appropriate. Should complement — not replace — formal cognitive rehabilitation.
Working memory, sustained attention, Go/No-Go, and inhibitory control training. Evidence supports cognitive training as an adjunct to medication and behavioural therapy in ADHD populations.
Low-load cognitive engagement during recovery. Maintains neural engagement without the depletion response that worsens burnout. Emotional regulation training is particularly relevant.
Structured daily cognitive engagement for healthy older adults. Consistent with cognitive reserve hypothesis literature. Category fluency tasks are directly relevant to dementia surveillance.
Emotional regulation mode (vagal brake training, cognitive reappraisal, stress inoculation) has a strong clinical evidence base. Appropriate as a self-directed complement to therapy.
May be appropriate once out of acute phase with therapist guidance. Difficulty levels may need monitoring. Not a substitute for formal cognitive rehabilitation programme.
Structured engagement is consistent with MCI management guidelines. However, monitor for frustration, which may exacerbate. Use Restore mode. Regular clinical monitoring recommended.
Cognitive training has modest evidence in depression as an adjunct. Monitor for frustration or negative comparison with previous function, which can worsen mood. Emotional regulation mode may be beneficial.
Not appropriate during acute psychosis, severe depressive episode, or manic episode. Not a substitute for acute psychiatric care. Not evaluated for these populations.
Cognitive demands exceed capacity in moderate-severe dementia. Not appropriate. Family caregivers may benefit from their own use but this is not a patient intervention for this population.
Minimum age is 16. The platform has not been evaluated in paediatric populations. Tasks and norms are calibrated for adult users.
Contact clinical@soillse.com to request a provider account. You'll receive a referral code patients can enter at signup. This links them to your provider record (with their consent) and allows you to receive their progress reports.
The 15-minute baseline assessment covers all 11 cognitive domains. It produces a domain score profile and a Brain Score. The standardised mapping table (above) provides approximate clinical context. Recommend patients complete 3 sessions before the next appointment for a meaningful baseline.
From the Progress screen → "Generate Report for Healthcare Provider." The report includes: session frequency, domain score changes, Brain Score trend, standardised mapping approximations, and a plain-language Sage summary. The patient can download a PDF or share a secure link directly with you.
Domain score changes over 8-12 sessions are the most meaningful signal. Single-session scores have high variability. Consistent improvement in a relevant domain (e.g., processing speed in post-COVID, verbal fluency in MCI monitoring) is clinically meaningful. Consistent decline warrants further assessment.
Restore mode has no timers, no failure states, and self-paced difficulty. It is specifically designed for TBI recovery, post-COVID, burnout, and older adults. Recommended: 3 sessions per week, 15-20 minutes each, during the sub-acute and chronic phases of recovery. Not a substitute for formal OT or neuropsychology input.
We are committed to not overstating what Soillse does. The following questions remain open:
The paradigms Soillse uses have shown near transfer in research settings (improvement on similar tasks). Far transfer — improvement in daily cognitive functioning — is less consistently demonstrated in the cognitive training literature. We do not claim Soillse produces broad real-world cognitive improvement. We claim it trains specific cognitive systems with validated methods.
No. The paradigms are validated. The specific game implementations in Soillse have not been tested in clinical trials. We are not aware of any consumer brain training app that has platform-level validation. We believe this is a structural gap in the industry that peer-reviewed research needs to address.
Cognitive training research consistently shows that engagement and session frequency are strong predictors of outcome. Users who complete 10+ sessions per month show more consistent domain improvements than infrequent users. The optimal "dose" for specific clinical populations is unknown.
The mappings are approximations based on task similarity, not empirical validation against normative data. We are actively working to collect data to improve these mappings. Until validated, they should be treated as indicative only.
We are actively seeking partnerships with academic researchers, cognitive-science labs, and wellness organisations interested in rigorous, honestly-scoped consumer tools — and we welcome scrutiny of our evidence claims. (We are a wellness product, not a clinical servich groups. If you are conducting research in cognitive rehabilitation, aging, ADHD, TBI, or related areas, we would welcome a conversation about how Soillse's data infrastructure could support your work.
We can provide: anonymised aggregate performance data, research access accounts, integration support, and co-design of research protocols. We are also seeking IRB-approved clinical trials to generate the platform-level outcome data the field needs.
For clinical enquiries, referral codes, research partnerships, and provider accounts:
We aim to respond to clinical enquiries within 2 business days.